These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2409069)

  • 1. Modification of pulmonary oxygen toxicity by bleomycin treatment.
    Matalon S; Harper WV; Goldinger JM; Nickerson PA; Olszowka J
    J Appl Physiol (1985); 1985 Jun; 58(6):1802-9. PubMed ID: 2409069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous bleomycin does not alter the toxic effects of hyperoxia in rabbits.
    Matalon S; Harper WV; Nickerson PA; Olszowka J
    Anesthesiology; 1986 May; 64(5):614-9. PubMed ID: 2421613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of O2 tolerance in rabbits with no increase in antioxidant enzymes.
    Baker RR; Holm BA; Panus PC; Matalon S
    J Appl Physiol (1985); 1989 Apr; 66(4):1679-84. PubMed ID: 2732159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of oxygen toxicity after lung injury by bleomycin in hamsters.
    Rinaldo J; Goldstein RH; Snider GL
    Am Rev Respir Dis; 1982 Dec; 126(6):1030-3. PubMed ID: 6185022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of an additional fibrotic response caused by oxygen in the lungs of rats after the intratracheal administration of bleomycin.
    Veninga TS; Vriesendorp R; Blom-Muilwijk MC; Sleyfer DT; Konings AW
    Br J Anaesth; 1988 Oct; 61(4):413-8. PubMed ID: 2461215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.
    Ekimoto H; Takada K; Takahashi K; Matsuda A; Takita T; Umezawa H
    J Antibiot (Tokyo); 1984 Jun; 37(6):659-63. PubMed ID: 6204963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Misra HP; Chandler DB; Chen ZL
    Exp Mol Pathol; 1983 Dec; 39(3):317-26. PubMed ID: 6196228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide.
    Phan SH; Fantone JC
    Lab Invest; 1984 May; 50(5):587-91. PubMed ID: 6201676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary toxicity of bleomycin in the rabbit: histophysiological and anatomo-radiological correlations].
    Bellet-Barthas M; Le Roy JP; Barthelemy L; Bellet M
    Toxicol Eur Res; 1983 May; 5(3):113-6. PubMed ID: 6195768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive pulmonary fibrosis in rats: a biochemical, cell kinetic, and morphologic analysis.
    Tryka AF; Witschi H; Lindenschmidt RC
    Exp Mol Pathol; 1985 Dec; 43(3):348-58. PubMed ID: 2415389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
    Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
    J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.
    Iraz M; Erdogan H; Kotuk M; Yağmurca M; Kilic T; Ermis H; Fadillioğlu E; Yildirim Z
    Pharmacol Res; 2006 Mar; 53(3):310-6. PubMed ID: 16459098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.
    Kennedy JI; Chandler DB; Jackson RM; Fulmer JD
    Chest; 1986 Mar; 89(3 Suppl):123S-125S. PubMed ID: 2419047
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
    Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
    J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal versus intravenous administration of bleomycin in mice: acute effects.
    Lindenschmidt RC; Tryka AF; Godfrey GA; Frome EL; Witschi H
    Toxicol Appl Pharmacol; 1986 Aug; 85(1):69-77. PubMed ID: 2425458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
    Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
    Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and levels of coenzyme Q10 in lung and liver in bleomycin-hamster model of lung fibrosis.
    Giri SN; Graver DF
    Toxicol Lett; 1991 Jan; 55(1):47-53. PubMed ID: 1705369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.